Retired/Replaced Guidelines

AAN guidelines can be retired for any of the following reasons:

  • The technology discussed in the guideline may be outdated
  • The conclusions and recommendations in the guideline may be unsafe
  • The guideline has been replaced by a more recent publication
  • There is a lack of resources to update the guideline

Displaying 1 - 20 out of 64 guidelines found

  1. Update: NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults

    April 2012

    Retired by the AAN Institute Board of Directors on September 16, 2015.

  2. The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis

    September 2008

    Retired guideline.

  3. Therapies for Benign Paroxysmal Positional Vertigo

    May 2008

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  4. Evaluating an Apparent Unprovoked First Seizure in Adults

    November 2007

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  5. Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesias

    April 2006

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  6. Diagnosis and Prognosis of New Onset Parkinson Disease

    April 2006

    Retired by the AAN Institute Board of Directors on March 9, 2016.

  7. Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease

    April 2006

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  8. Therapies for Essential Tremor

    June 2005

    Updated by "Evidence-based Guideline Update: Treatment of Essential Tremor" (June 2011).

  9. Treatment of Postherpetic Neuralgia

    September 2004

    Reaffirmed on February 8, 2008. Retired by the AAN Institute Board of Directors on February 27, 2018.

  10. Transcranial Doppler Ultrasonography UPDATED

    May 2004

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  11. Recurrent Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm

    April 2004

    Retired and replaced by "Practice Advisory: Recurrent Stroke With Patent Foramen Ovale (Update Of Practice Parameter)" (July 2016)

  12. Utility of MRI in Suspected MS

    September 2003

    Retired by the AAN Institute Board of Directors on March 8, 2016.

  13. Neuroimaging of the Neonate

    June 2002

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  14. Electrodiagnostic Studies in Carpal Tunnel Syndrome

    June 2002

    Retired guideline.

  15. Steroids, Acyclovir, and Surgery for Bell's Palsy

    April 2001

    Replaced by "Update: Steroids and Antivirals for Bell Palsy" (November 2012).

  16. Evidence-based Guidelines for Migraine Headache

    September 2000

    Replaced by "Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults" (April 2012).

  17. Clinical Utility of Surface EMG

    July 2000

    Retired by the AAN Board of Directors on December 9, 2006.

  18. The Role of Corticosteroids in the Management of Acute Monosymptomatic Optic Neuritis

    June 2000

    Retired by the AAN Board of Directors on January 2007.

  19. Anticonvulsant Prophylaxis in Patients with Newly Diagnosed Brain Tumors

    May 2000

    Retired by the AAN Institute Board of Directors on June 4, 2012.

  20. Risk of Driving and Alzheimer's Disease

    January 2000

    Retired and replaced by "Update: Evaluation and Management of Driving Risk in Dementia" (April 2010).

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer